North Carolina Central University & the Duke Cancer Institute: TWO Postdoctoral Fellowships In Translational Cancer Disparities Research

The National Cancer Institute awarded a P20 Feasibility Studies to Build Collaborative Partnerships in Cancer Research Grant to North Carolina Central University (NCCU) and the Duke Cancer Institute (DCI) on September 20, 2016. A major goal of the NCI P20 partnership program is to provide support for investigators at ISUPS and NCI-designated Cancer Centers to conduct joint cancer research pilot projects and education programs, to allow awardees to obtain preliminary data that will lead to their submission of competitive grant applications to the NIH/NCI. In addition, outreach education efforts at Cancer Centers may result in increased participation of underserved patients in cancer and/or cancer health disparities-related clinical trials.

Towards achieving this goal, the NCCU-DCI Cancer Disparities Translational Research Partnership (CDTRP) is seeking applications to fill two postdoctoral positions for candidates with an interest in translational cancer health disparities research for breast or prostate cancer. Projects are focused on (i) using molecular and drug development strategies to define critical steps in carcinogenesis and cancer progression including transcriptomic analysis of breast cancer models and samples. (ii) Interrogating and modulating, for therapeutic application, the molecular mechanisms underlying the more aggressive prostate cancer biology in African American men and elucidating the importance of these mechanisms for response to current therapeutic strategies.

Applications from talented, well-trained, and passionate researchers from those populations affected by disparities in cancer outcomes are encouraged.

Qualifications and Experience

A Ph.D. in a biology-related discipline is required: genetics, genomics, molecular biology, cancer biology, biochemistry, pharmaceutical sciences, or a related discipline, as well as a record of publication and independence. Research experience is particularly desirable in molecular biology and genomic profiling.

Qualities sought: Demonstrates critical thinking skills, highly developed interpersonal skills, outstanding communication skills, collaborative, and a high level of self-motivation. Use of statistics and experience with scientific writing, the ability to perform detailed work, multi-task, and problem solve. Proficient in computer and molecular biology skills and utilizing imaging and analysis software. Cell culture and working with various murine models is a benefit, but not required.

How to Apply

The positions are within the Department of Pharmaceutical Sciences at North Carolina Central University and Duke Cancer Institute, both located in Durham, North Carolina. Applicants should submit curriculum vitae with publications, research interests, and the names and contact information for three references. Review of applicants will begin immediately and continue until the position is filled. Postdoc stipends will follow current NIH guidelines.

Applications should be sent electronically to both Program Managers: Dr. Holly Hough, [email protected] and Ms. Vonná Woodard, [email protected]. Dr. Kevin Williams is the NCCU PI for P20 CDTRP and Dr. Steven Patierno is the Duke PI for P20 CDTRP.

Duke University and NCCU are Affirmative Action/Equal Opportunity Employers committed to providing employment opportunity without regard to an individual’s race, color, religion, age, gender, sexual orientation, national origin, genetic information, veteran status, or disability. This position is subject to a background investigation.


Editor’s note: MinorityPostdoc.org publishes postdoctoral & professional job / opportunity advertisements. When participating in these opportunities, please mention that you saw the ad here. Advertisers can request information on rates and terms by contacting us at

last updated 1-Dec-2017